Zhiping Guo

NO. 5, East Third Lane, Jiefang Road
Taiyuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum to "Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification" [Leukemia Research Reports 24 (2025) 100550].

Corrigendum to "Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification" [Leukemia Research Reports 24 (2025) 100550].

Journal: Leukemia research reports

Published: December 30, 2025

Case report: Different outcomes of two cases of relapsed/refractory T cell acute lymphoblastic leukemia treated with anti-CD7 chimeric antigen receptor T cells bridging to allogeneic hematopoietic stem cell transplantation: from curative promise to fatal risk.

Case report: Different outcomes of two cases of relapsed/refractory T cell acute lymphoblastic leukemia treated with anti-CD7 chimeric antigen receptor T cells bridging to allogeneic hematopoietic stem cell transplantation: from curative promise to fatal risk.

Journal: Frontiers in oncology

Published: December 13, 2025

Mammalian target of rapamycin inhibitors as the treatment for steroid-refractory acute graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: A systematic review and individual patient data meta-analysis.

Mammalian target of rapamycin inhibitors as the treatment for steroid-refractory acute graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: A systematic review and individual patient data meta-analysis.

Journal: Experimental and therapeutic medicine

Published: May 27, 2025

Potential Off-Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild-Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms.

Potential Off-Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild-Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms.

Journal: Case reports in hematology

Published: May 08, 2025

Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification.

Unveiling prognosis in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax through novel risk stratification.

Journal: Leukemia research reports

Published: April 22, 2025

Peripheral Blood Lymphocyte Subsets in Factor VIII Inhibitor-Positive Patients with Severe Hemophilia A: A Case-Control Study.

Peripheral Blood Lymphocyte Subsets in Factor VIII Inhibitor-Positive Patients with Severe Hemophilia A: A Case-Control Study.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: August 16, 2024

Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.

Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.

Journal: Blood cells, molecules & diseases

Published: September 24, 2019

Genetic diagnosis and bioinformatic analysis of a pedigree with inherited factor VII deficiency

Genetic diagnosis and bioinformatic analysis of a pedigree with inherited factor VII deficiency

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 18, 2015

Study on the correlation between FcγR IIIA-158V/F single nucleotide polymorphisms and adult primary immune thrombocytopenia

Study on the correlation between FcγR IIIA-158V/F single nucleotide polymorphisms and adult primary immune thrombocytopenia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 27, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026